Other Non-Current Liabilities
Bristol-Myers Squibb Other Non-Current Liabilities decreased by 3.8% to $4.85B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.4%, from $4.48B to $4.85B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -8.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A steady increase may indicate growing long-term commitments, such as pension obligations or environmental liabilities, which could impact future cash flows.
Detailed definition
This category includes long-term obligations that do not fall into standard debt or tax categories, such as pension liab...
Peer comparison
Varies significantly across the industry based on the age of the company and the nature of its manufacturing footprint.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.5B | $7.52B | $7.33B | $7.31B | $6.64B | $6.69B | $6.59B | $6.66B | $5.9B | $6.2B | $6.42B | $6.73B | $4.99B | $4.73B | $4.47B | $4.48B | $4.94B | $5.46B | $5.04B | $4.85B |
| QoQ Change | — | +0.2% | -2.4% | -0.3% | -9.2% | +0.7% | -1.4% | +1.1% | -11.4% | +5.1% | +3.5% | +4.8% | -25.8% | -5.3% | -5.5% | +0.2% | +10.4% | +10.5% | -7.6% | -3.8% |
| YoY Change | — | — | — | — | -11.4% | -11.1% | -10.1% | -8.8% | -11.1% | -7.2% | -2.6% | +1.0% | -15.4% | -23.8% | -30.4% | -33.5% | -1.0% | +15.5% | +12.8% | +8.4% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's other non-current liabilities?
- Bristol-Myers Squibb (BMY) reported other non-current liabilities of $4.85B in Q1 2026.
- How has Bristol-Myers Squibb's other non-current liabilities changed year-over-year?
- Bristol-Myers Squibb's other non-current liabilities increased by 8.4% year-over-year, from $4.48B to $4.85B.
- What is the long-term trend for Bristol-Myers Squibb's other non-current liabilities?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's other non-current liabilities has grown at a -8.3% compound annual growth rate (CAGR), from $7.78B to $5.04B.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations that are not classified as debt or deferred taxes.